NeuroOne Medical Technologies Corporation - Common Stock (NMTC)

--News Direct--

--News Direct--

--News Direct--

NMTC stock results show that NeuroOne Medical Tech met analyst estimates for earnings per share but missed on revenue for the third quarter of 2024.

Given the high bar to developing good neuroscience drugs, firms that do so will likely succeed. Here are three top biotech stocks to buy now. 

These neurotech stocks stand at the cutting edge of healthcare, but early entrants in new fields tend to be long-term winners.

NMTC stock results show that NeuroOne Medical Tech missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

NMTC stock results show that NeuroOne Medical Tech beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Companies Reporting Before The Bell • Live Ventures (NASDAQ:LIVE) is estimated to report earnings for its fourth quarter. • Jabil (NYSE:JBL) is projected to report earnings for its first quarter.

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.

It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.